ABIG Signal
Healthcare news moves fast. We tell you what it means for your business.
ABIG Signal is the official newsletter of ABIG Health, written for the people navigating healthcare's most complex decisions.
Every issue goes beyond the headline. We analyze the latest in healthcare policy, regulatory updates, and market shifts and connect them directly to what matters most: commercial outcomes, reimbursement implications, market access strategy, and what founders, executives, and investors should do next.
If you're building, scaling, or investing in healthcare, this is your signal.
LATEST ISSUE
ABIG Signal — Medicine and Margins
August 2026 · Issue 15
AI climbed into the operating room and the diagnosis itself while the FDA sat without a permanent chief, Washington spent the fortnight reshuffling who gets paid by tilting Medicare toward primary care and freezing blue-state Medicaid dollars, and policy bit into earnings even as the checkbooks stayed open, from a rare CRISPR IPO to Medtronic's latest buyout.
Looking for Earlier Newsletters? Explore our previous newsletter series in the Newsletter Archive.
Newsletter 2026
-
AI Rulebooks Meet the Money
The biggest AI labs pushed for their own federal rulebook as hospitals quietly made AI infrastructure, Washington propped up physician pay while cutting hospitals' 340B dollars and ACA premiums climbed again, and the checkbooks stayed open, from Eli Lilly's first psychedelics buy…
-
Spending Races Ahead of Trust
UnitedHealth bet $3B on AI as Congress and HHS split over Medicare's WISeR pilot, the government squeezed hospital contracting and blue-state Medicaid while loosening the reins on wearables and trials, and ACA coverage slid, but capital kept flowing…
-
AI Cost Pressures and Medicare's Looming Horizon
Administrative artificial intelligence adoption is driving near-term commercial cost projections upward, not downward; Medicare faces tightening insolvency timelines, alongside a massive spike in senior GLP-1 utilization; and market-wide, global pharmaceutical manufacturers..
-
Clinical AI Wins, Political AI Loses
Spring 2026 revealed healthcare AI's split personality: clinical applications like Utah's prescription renewal pilot and OpenEvidence's voice interface gained traction while Congress moved to kill Medicare's WISeR prior authorization model…
-
Oversight Awakening and Industry Consolidation
Healthcare's regulatory oversight is awakening to realities reshaping the industry; AI developments continues at pace; federal health leadership remains unstable with enforcement expanding; and capital flows toward mega-deals and consolidation even as basic delivery infrastructure…
-
Innovation Boom, Infrastructure Bust
Billion-dollar AI investments and record biotech IPOs collide with a suspended AI prescription program, long-term care hospital closures, and PBM reform blocked in courts — healthcare is splitting into innovation haves and infrastructure have-nots…
-
Healthcare's Split Screen
Record private investment in AI and consolidation meets aggressive government enforcement and funding cuts. While venture capital pours billions into Medicare navigation and wearables, regulators launch multi-front crackdowns and states prep massive Medicaid reductions…
-
Big Bets, Bigger Crackdowns
Healthcare's spring paradox is in full swing: billions in M&A deals and millions in AI funding, while regulators launch coordinated enforcement across antitrust, consumer protection, and AI transparency. Private capital is doubling down on enterprise AI and cancer diagnostics just…
-
Everything, Everywhere, All At Once
Federal policy is sprinting on AI for Medicare, MFN pricing, biosimilar streamlining, and non-network ACA plans, but keeps hitting structural walls. Meanwhile, the private sector is solving around what government can't regulate into existence through advocacy, settlements, and…
-
Health Care’s Two-Speed System
Healthcare technology is scaling rapidly through massive M&A deals and AI infrastructure buildouts, while political battles over fraud investigations, nursing education funding, and Medicare Advantage market exits are creating widespread disruption for patients…
-
Let Them Eat (Less) Cake
Healthcare technology is advancing at breakneck speed with AI predicting disease and major insurers betting on digital chronic care, while Washington finally delivered PBM transparency and Republicans hunt marketplace fraud. The disconnect? All this innovation is…
-
The More Things Change…
Washington can't get out of its own way, but the money is still moving, and organizations without AI guardrails are falling behind. Congress stumbled through another shutdown, while CMS signaled it's done tolerating MA upcoding. AI chatbots prove the #1 technology hazard…
-
The ABIG Update
Money is pouring into AI, rules are nowhere to be found, and Washington spent the week tripping over itself. At JPM, Dr. Oz called trillion-dollar Medicaid cuts "catastrophizing," health systems swapped growth talk for survival mode, and Boston Scientific broke the megadeal drought with…
-
ABIG 2026 Ahead: Reflections and Forecasts
2025 closed with subsidies lapsing, measles surging, and industry warning of turbulence ahead; 2026 opened with vaccine policy being rewritten overnight and fresh deal-making on the Hill. The system is under strain, but so is the status quo. AI adoption is accelerating…